Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 44 | SFEBES2016 | Next issue

Society for Endocrinology BES 2016

Brighton, UK
07 Nov 2016 - 09 Nov 2016

Card image cap
07 Nov 2016 to 09 Nov 2016 Brighton, UK Further information

Clinical Management Workshops

Workshop 3: How do I…

ea0044cmw3.1 | Workshop 3: How do I… | SFEBES2016

How I approach Drug-Induced Hyperprolactinaemia

Newey Paul

Drug-induced hyperprolactinaemia is a frequently encountered clinical entity due to the large number of commonly prescribed medications that may influence prolactin secretion. Anti-psychotics, anti-depressants and anti-emetics are most frequently culpable, predominantly due to inhibitory effects on hypothalamic-pituitary dopamine signalling. The onset and severity of hyperprolactinaemia may be highly variable, and individuals may harbour typical symptoms (e.g. galactorrhoea, a...

ea0044cmw3.2 | Workshop 3: How do I… | SFEBES2016

Abstract unavailable....

ea0044cmw3.3 | Workshop 3: How do I… | SFEBES2016

Abstract unavailable....

ea0044cmw3.4 | Workshop 3: How do I… | SFEBES2016

How do I manage refractory hypercalcaemia?

Turner Jeremy

Hypercalcaemia is a moderately common condition accounting for approximately 1% of all acute general medical presentations. Guidance on emergency management of the hypercalcaemic patient, aimed primarily at the generalist and at guiding initial stages of management has recently been developed by the society (https://www.endocrinology.org/policy/docs/13-02_EmergencyGuidance-Acute...

ea0044cmw3.5 | Workshop 3: How do I… | SFEBES2016

How do I prepare a patient for phaeo surgery?

Sam Amir

All patients with phaeochromocytoma should undergo surgical resection by an experienced surgeon. Surgery should only be carried out after adequate medical preparation to minimize catecholamine-related adverse events. Pre-operative pharmacologic treatment is aimed at controlling hypertension and tachycardia, and volume expansion. This session will summarise the current practice in the medical management of patients with phaeochromocytoma at Hammersmith Hospital....

ea0044cmw3.6 | Workshop 3: How do I… | SFEBES2016

How do I determine Cortisol deficiency in the critically ill patient?

Tomlinson Jeremy

Critical illness is associated with significant morbidity and mortality. The changes in the hypothalamo-pituitary-adrenal (HPA) axis that occur during critical illness are complex and whilst early studies had suggested improved outcome in patients with septic shock treated with parenteral glucocorticoids, this was not endorsed in subsequent studies and it remains a highly controversial area.In patients with underlying pituitary or adrenal disease where c...